Healthcare advocates are reportedly fighting hard against a Trump Administration Moves to End Medicare Part D Subsidy Program that has helped stabilise prescription drug coverage for millions of Americans. The ruling is being debated by patient groups, insurers, health care providers and policy makers, with supporters and critics offering sharply different perspectives on how the…

Continue Reading